Given 5mg daily. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy1

Organisms1

Diseases34

Recurrence Duodenal Ulcer Hypertension Body Weight Hypercholesterolemia Esophagitis Hypokalemia Leukemia, Myeloid, Chronic-Phase Disease Progression Peptic Ulcer Arthritis, Rheumatoid Diabetes Mellitus, Type 2 Hemorrhage Chronic Disease Breast Neoplasms Exanthema Duodenogastric Reflux Pain Stomach Ulcer Drug Eruptions Gastroesophageal Reflux Osteoporosis, Postmenopausal Leukemia, Myelogenous, Chronic, BCR-ABL Positive Stroke Cardiovascular Diseases Asthma Esophagitis, Peptic Neoplasm Recurrence, Local Nausea Gastrointestinal Stromal Tumors Proteinuria Neoplasms Substance Withdrawal Syndrome Weight Gain

Chemicals and Drugs152

Placebos Omeprazole Aspirin Anti-Ulcer Agents Thalidomide Simvastatin Pyrimidines Piperazines Pyrroles Prednisolone Anticholesteremic Agents Benzamides Labetalol Heptanoic Acids Platelet Aggregation Inhibitors 2-Pyridinylmethylsulfinylbenzimidazoles Protriptyline Benzimidazoles Hydroxymethylglutaryl-CoA Reductase Inhibitors Fluorobenzenes Quinazolines Bendroflumethiazide Phenylbutazone Antineoplastic Agents Ticlopidine Triazoles Anti-Inflammatory Agents, Non-Steroidal Sodium Chloride Symporter Inhibitors Apazone Cimetidine Sulfonamides Antihypertensive Agents Nitriles Anti-Inflammatory Agents Delayed-Action Preparations Atenolol Ketoconazole Alendronate Enalapril Spironolactone Thiophenes Metoprolol Hydrochlorothiazide Angiotensin-Converting Enzyme Inhibitors Lansoprazole Drug Combinations Indoles Ranitidine Estrogens, Conjugated (USP)Pyridines Sulfoxides Norethindrone Budesonide Azetidines Cholesterol, LDL Quinolines Celiprolol Norpregnenes Etidronic Acid Purinergic P2Y Receptor Antagonists Piracetam Protein Kinase Inhibitors Diuretics Hypolipidemic Agents Amlodipine Canrenone Guanfacine Pregnenediones Proton Pump Inhibitors Prednisone Aromatase Inhibitors Losartan Fluconazole Propanolamines Antineoplastic Agents, Hormonal Esomeprazole Thiazoles Androstadienes Tamoxifen Ethanolamines Progesterone Congeners Warfarin Glucocorticoids Anilides Naproxen Biological Markers Azithromycin Lovastatin Rifabutin Lipids Anticonvulsants Thiazolidinediones Aminoglutethimide Estradiol Antiviral Agents Sulfones Lamivudine Antifungal Agents Pyrazoles Phenylurea Compounds Tetrazoles Digoxin Adrenergic beta-Antagonists Rifampin Pravastatin Isoxazoles Creatinine Blood Glucose Antidepressive Agents, Second-Generation Lisinopril Dexamethasone Anti-Bacterial Agents Sirolimus Estrogen Antagonists Carbamazepine Hydrocortisone Bromocriptine Benzoates Cyclooxygenase Inhibitors Fenofibrate Propranolol Niacinamide Hypoglycemic Agents Indans Perindopril Clarithromycin Bone Density Conservation Agents C-Reactive Protein Angiotensin II Type 1 Receptor Blockers Indapamide Cyclooxygenase 2 Inhibitors Medroxyprogesterone Acetate Ascorbic Acid Fumarates Lactones Anticoagulants Enzyme Inhibitors Interferon-alpha Piperidines Serotonin Uptake Inhibitors Cholesterol Nifedipine Androgen Antagonists Albuterol Histamine H2 Antagonists Plant Extracts Immunosuppressive Agents Doxycycline Antioxidants Angiogenesis Inhibitors Quinolones Estrogen Receptor Modulators

Analytical, Diagnostic and Therapeutic Techniques and Equipment48

Double-Blind Method Drug Administration Schedule Treatment Outcome Activities of Daily Living Administration, Oral Drug Therapy, Combination Placebos Cross-Over Studies Clinical Trials as Topic Prospective Studies Follow-Up Studies Random Allocation Single-Blind Method Blood Pressure Area Under Curve Drug Evaluation Antineoplastic Combined Chemotherapy Protocols Delayed-Action Preparations Pilot Projects Maximum Tolerated Dose Disease-Free Survival Treatment Failure Body Weight Severity of Illness Index Platelet Function Tests Analysis of Variance Heart Rate Risk Factors Randomized Controlled Trials as Topic Remission Induction Peak Expiratory Flow Rate Survival Rate Questionnaires Kaplan-Meier Estimate Retrospective Studies Gastric Acidity Determination Combined Modality Therapy Infusions, Intravenous Survival Analysis Endoscopy, Gastrointestinal Injections, Intravenous Pain Measurement Cohort Studies Incidence Metabolic Clearance Rate Estrogen Replacement Therapy Administration, Cutaneous Drug Monitoring

Psychiatry and Psychology4

Patient Compliance Pain Motor Activity Substance Withdrawal Syndrome

Phenomena and Processes23

Dose-Response Relationship, Drug Time Factors Drug Interactions Blood Pressure Area Under Curve Maximum Tolerated Dose Postmenopause Body Weight Half-Life Circadian Rhythm Heart Rate Drug Tolerance Peak Expiratory Flow Rate Biological Availability Pain Pregnancy Drug Resistance Eating Diet Metabolic Clearance Rate Bone Density Motor Activity Weight Gain

Anthropology, Education, Sociology and Social Phenomena2

Activities of Daily Living Quality of Life

Technology, Industry, Agriculture2

Dietary Supplements Animal Feed

Humanities1

Quality of Life

Information Science3

Survival Rate Questionnaires Incidence

Health Care25

Double-Blind Method Treatment Outcome Activities of Daily Living Cross-Over Studies Clinical Trials as Topic Prospective Studies Follow-Up Studies Random Allocation Single-Blind Method Area Under Curve Pilot Projects Disease-Free Survival Patient Compliance Treatment Failure Severity of Illness Index Analysis of Variance Risk Factors Randomized Controlled Trials as Topic Survival Rate Questionnaires Kaplan-Meier Estimate Retrospective Studies Survival Analysis Cohort Studies Incidence

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Health Care

Double-Blind Method Drug Administration Schedule Treatment Outcome Activities of Daily Living Administration, Oral Drug Therapy, Combination Dose-Response Relationship, Drug Placebos Omeprazole Cross-Over Studies Aspirin Time Factors Anti-Ulcer Agents Thalidomide Simvastatin Pyrimidines Clinical Trials as Topic Prospective Studies Piperazines Drug Interactions Pyrroles Prednisolone Anticholesteremic Agents Follow-Up Studies Benzamides Random Allocation Labetalol Heptanoic Acids Platelet Aggregation Inhibitors 2-Pyridinylmethylsulfinylbenzimidazoles Recurrence Protriptyline Benzimidazoles Hydroxymethylglutaryl-CoA Reductase Inhibitors Fluorobenzenes Quinazolines Bendroflumethiazide Single-Blind Method Phenylbutazone Blood Pressure Antineoplastic Agents Area Under Curve Ticlopidine Triazoles Anti-Inflammatory Agents, Non-Steroidal Drug Evaluation Sodium Chloride Symporter Inhibitors Antineoplastic Combined Chemotherapy Protocols Apazone Cimetidine Duodenal Ulcer Sulfonamides Antihypertensive Agents Hypertension Nitriles Anti-Inflammatory Agents Delayed-Action Preparations Pilot Projects Atenolol Maximum Tolerated Dose Tribulus Ketoconazole Disease-Free Survival Alendronate Enalapril Spironolactone Thiophenes Dietary Supplements Postmenopause Patient Compliance Treatment Failure Body Weight Metoprolol Hydrochlorothiazide Angiotensin-Converting Enzyme Inhibitors Severity of Illness Index Lansoprazole Drug Combinations Indoles Ranitidine Estrogens, Conjugated (USP)Pyridines Half-Life Sulfoxides Norethindrone Budesonide Gastric Acid Hypercholesterolemia Azetidines Cholesterol, LDL Esophagitis Quinolines Celiprolol Hypokalemia Platelet Function Tests Norpregnenes Etidronic Acid Purinergic P2Y Receptor Antagonists Piracetam Protein Kinase Inhibitors

No FAQ available that match "given 5mg daily"